Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares RMEAX

Morningstar Medalist Rating
  • NAV / 1-Day Return$17.68  /  −1.12%
  • Fund Size$1.4B
  • Adjusted Expense Ratio0.950%
  • Net Expense Ratio0.290%
  • Fee Level: DistributionAverage
  • Share Class TypeNo Load
  • Morningstar CategoryGlobal Large-Stock Blend
  • Equity Style Box (Funds)Large Blend
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield1.39%
  • Turnover Ratio21%

Morningstar’s Analysis RMEAX

Will RMEAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Aspiriant Risk-Managed Equity Allc Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RMEAX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings73.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GMO Quality VI

33.79493M
—

Schwab Fundamental Emerging MarketsEqETF

7.34107M
—

RIEF STRATEGIC PARTNERS FUND

6.96102M
—

Baillie Gifford Emerging Markets Eqs K

5.2376M
—

GMO Equity Dislocation Invmt A USD Acc

4.5166M
—

AQR Large Cap Defensive Style R6

3.8356M
—

iShares MSCI ACWI ETF

3.3549M
—

iShares MSCI Global Min Vol Factor ETF

3.3349M
—

Viking Global Equities Lp

3.3349M
—

JPMorgan Prime Money Market Inst

3.1546M
Cash and Equivalents

Sponsor Center